Summary
Wyse and Meyer (2023) construct a population-level administrative linkage of 37.5 million non-disabled low-income adults (ages 19–59, income <138% of the federal poverty level [FPL]) using the 2010 Census, IRS Modified Adjusted Gross Income (MAGI) records, Centers for Medicare & Medicaid Services (CMS) Medicaid enrollment data, and Social Security Administration (SSA) Numident mortality records through April 2022. Using staggered difference-in-differences (DiD) on Affordable Care Act (ACA) Medicaid expansion timing across states and a discrete-time proportional hazard model, they find that expansions raised Medicaid enrollment by +11.7 percentage points (pp) and reduced annual mortality hazard by 2.5% (intention-to-treat, ITT) or 21% for new enrollees (treatment on the treated, TOT). The paper estimates that 27,400 lives were saved in expansion states 2010–2022, with 43% of the ~830,890 life-years saved accruing to adults ages 19–39 due to their longer remaining life expectancy. The paper uses a preregistered analysis plan — only the second nonexperimental economics study to do so — and finds that universal Medicaid coverage would close only 5–20% of the mortality gap between the highest and lowest income quintiles.
Key Claims
- Sample and linkage: 37.5 million non-elderly (ages 19–59), non-disabled adults with incomes <138% FPL in the 2010 Census linked to IRS administrative MAGI income records (more accurate than self-reported income for eligibility identification), CMS Medicaid enrollment records, and SSA Numident all-cause mortality through April 2022. Sample is 60× larger than the second-largest comparable study (Miller, Johnson, and Wherry 2021, N ≈ 566,000).
- Preregistration: One of only two nonexperimental economics studies with a preregistered analysis plan (Neumark 2001 is the other), preventing specification searching on a heavily contested empirical question.
- Identification: Staggered DiD exploiting variation in state Medicaid expansion timing — pre-ACA waivers (Delaware, Massachusetts), early expanders (2010–2011), and the modal 2014 expansion wave — with state and year fixed effects; discrete-time proportional hazard model with non-parametric baseline hazard; state-clustered standard errors.
- First stage: Expansions raised Medicaid enrollment by +11.7 pp from a 24% pre-expansion baseline (~+35.9 days/year of coverage per eligible adult). ~28.7 million additional person-years of enrollment attributable to expansions 2010–2022.
- ITT mortality effect: −2.5% reduction in annual mortality hazard in expansion states (95% confidence interval [CI]: −0.43% to −4.5%), significant at 5%. The smaller ITT relative to Miller et al. (2021)'s −9.4% reflects (a) a broader age range including younger adults with lower baseline mortality and (b) different pre-expansion enrollment rates.
- TOT mortality effect: −21% reduction in annual mortality hazard for new enrollees (95% CI: −3.7% to −38%), assuming no spillovers to unenrolled individuals. A triple-difference using 4–6x FPL adults as a comparison group yields TOT −17.7% (CI: −3.4% to −32%), consistent with the main estimate.
- Lives saved:
27,400 lives saved in expansion states 2010–2022 (3,220 per year). ~12,800 additional avoidable deaths in non-expansion states had they expanded by 2014. Scaling to the full 13-year horizon, the cost of non-expansion is approximately 4,400 deaths/year.
- Life-years saved: ~830,890 total life-years saved 2010–2022. 43% accrued to adults ages 19–39 despite only ~15–29% of lives saved being from that age group, because younger adults have 30–40 more life-years remaining at typical death ages.
- Age heterogeneity in TOT: Proportional TOT effects are consistently negative and similar in magnitude across all age groups (ages 19–29: −25.8%; 30–39: −27.1%; 40–49: −15.6%; 50–59: −17.4%). Only ages 50–59 is statistically significant at 95%; ages 30–39 and 40–49 at 90%; ages 19–29 not significant. Signs are consistently negative across all subgroups including race, gender, income level, family structure, and employment status.
- Young adult mechanism — SUD and external causes: External causes (accidents [predominantly drug overdose poisonings], suicide, and homicide) account for >80% of deaths among adults ages 19–29 vs. only ~11% among ages 50–59. ACA Medicaid expansions significantly expanded substance use disorder (SUD) and mental health treatment coverage; waiver programs in many expansion states further extended residential SUD treatment. The paper hypothesizes that Medicaid reduces young adult mortality primarily via expanded SUD/mental health treatment access, reducing overdose deaths, suicide, and possibly violence-related mortality. No cause-of-death data available to test directly.
- Comparison to prior literature: Point estimates fall within the wide confidence intervals of Miller, Johnson, and Wherry (2021) QJE and Finkelstein et al. (2012) Oregon HIS Experiment, but at the lower end. The CI excludes Goldin, Lurie, and McCubbin (2021)'s very large mortality reduction. Prior studies' large point estimates may reflect underpowering, use of linear probability models (LPM; less efficient for binary outcomes), or overestimation from misidentification of the comparison group.
- Cost-effectiveness: $5.4M per life saved — well below the $10–11M federal value-of-a-statistical-life (VSL) threshold. $179,000 per life-year saved — below Braithwaite et al. (2008)'s $217,000–$313,000 societal willingness-to-pay threshold. Comparable to cervical cancer screening; more cost-effective than injury prevention and toxin regulation; less cost-effective than highly targeted medical interventions that concentrate on high-benefit recipients.
- Income-mortality gradient: Universal Medicaid enrollment would close 5–20% of the mortality gap between the highest and lowest income quintiles (Chetty et al. 2016 gradient). Middle range (around 12%) most likely given likely positive selection into Medicaid enrollment in the natural experiment. The majority of the income-mortality gradient — perhaps 80–95% — operates through channels other than lack of insurance access (human capital, behavioral pathways, neighborhood and built environment effects).
- Robustness checks: Higher-income (4–6x FPL) control group shows small Medicaid enrollment effect (+1.5 pp) and no detectable mortality effect, supporting the identification assumption. Event studies confirm parallel pre-expansion trends. Results are robust to including disabled individuals (though attenuated to −1.3%, p<0.10), to alternate definitions of expansion timing, and to alternative covariate specifications.
Concepts Introduced or Extended
Entities Mentioned
Quotes
"Our best estimates suggest that universal Medicaid would close roughly 12% of the gap in mortality rates between those in the highest and lowest income quintiles. Since insurance is just one of many factors that contribute to health and mortality, this finding suggests that health policies that focus solely on expanding health insurance coverage are only one part of the comprehensive strategy needed to close the income–mortality gradient."
"We find consistent, negative point estimates for all age groups, all racial and ethnic groups, both genders, all income levels, all family structures, and both employment statuses... the effect estimates for those in their 30s, 40s, and 50s account for most of the lives saved, but those in their 20s and 30s account for a large share of the life-years saved."
"We estimate that ACA Medicaid expansions led to approximately 27,400 lives saved in expansion states from 2010 to 2022, which equals approximately 3,220 per year."
My Take
This is the strongest paper in the Medicaid-mortality literature by most methodological dimensions: largest sample by far, preregistered analysis plan, best income identification (IRS MAGI vs. survey self-report), appropriate survival model (proportional hazard vs. LPM). The −21% TOT estimate is credible and well-supported. The finding that prior studies' very large estimates (Goldin et al. 2021: ~122%) are excluded by this paper's CI is an important methodological contribution — it identifies overcorrection as a likely source of upward bias in small-sample studies.
The most novel and provocative finding is the 5–20% gradient closure from universal Medicaid. This directly challenges the "healthcare access explains SES health disparities" narrative: even a fully-insured population would retain 80–95% of its income-mortality gradient, driven by other determinants (education, behaviors, built environment, stress). The paper is appropriately humble about this — it uses Chetty et al.'s gradient and applies Wyse-Meyer's TOT to compute implied closure, which involves extrapolation.
The young adult mechanism (SUD/external causes) is the most speculative element. It is plausible and the circumstantial evidence is strong (ACA SUD benefit expansion, overdose-dominated young adult deaths), but the paper has no utilization or cause-of-death data to confirm it. Future work with linked cause-of-death data could resolve this.
One methodological caveat: the staggered DiD design is theoretically sensitive to heterogeneous treatment effect timing of the kind flagged by Callaway-Sant'Anna (2021) and Goodman-Bacon (2021). The paper addresses this through event studies and triple-differences but does not formally implement recent staggered-DiD estimators — an acknowledged limitation. With treatment effects that appear to grow over time, this may matter.